Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Montelukast in the Treatment of Duodenal Eosinophilia

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by:
Children's Mercy Hospital Kansas City Identifier:
First received: September 6, 2005
Last updated: December 26, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):